Publications by authors named "T Bidder"
Objectives: Chronic rhinosinusitis (CRS) with severe asthma are associated with breathing pattern disorder (BPD). Mouth breathing is a sign of breathing pattern disorder, and nose breathing a fundamental part of breathing pattern retraining for BPD. The prevalence of BPD in relation to CRS subtypes and the relationship of nasal obstruction to BPD in CRS and associated severe asthma is unknown.
View Article and Find Full Text PDFArticle Synopsis
- - Chronic rhinosinusitis (CRS) is linked to high rates of anxiety and depression, but the effects of treatments, like omalizumab, on mental health are unclear.
- - A study of 95 patients with severe CRS and asthma measured anxiety and depression levels and found significant rates of anxiety (49.47%) and depression (38.95%) among participants, particularly in those with nasal polyps.
- - Treatment with omalizumab significantly reduced anxiety levels but did not affect depression scores; overall, symptoms related to CRS and asthma improved post-treatment, highlighting a connection between airway disease and anxiety.
Asthma is a chronic respiratory condition that can affect people of all ages. Globally, asthma is one of the most common non-communicable diseases and is associated with significant personal, financial and societal costs. In some cases, asthma can be fatal, although many fatalities would have been preventable with appropriate management.
View Article and Find Full Text PDFIntroduction: Chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma often coexist and thus treating both with one intervention is an attractive strategy.
Objective: To prospectively evaluate whether treatment with the monoclonal antibody against IgE Omalizumab for severe allergic asthma also effectively treats co-existent CRSwNP.
Methods: SNOT-22 and the ACQ-7 scores were recorded at 4 and 16 weeks of treatment in a cohort of patients with both CRSwNP and severe refractory allergic asthma treated with Omalizumab (n=13) according to UK guidelines for their severe asthma.